A study by researchers at the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) found that net primary productivity in Miscanthus × giganteus is driven by aboveground productivity, influenced by nitrogen application and site. The results provide useful data for agroecosystem models and crucial insights for future perennial belowground sampling, and will help improve understanding of the carbon sequestration potential of this perennial grass.

New York City’s roads and bridges already incur millions in annual damage from oversized trucks, and a new study warns the shift to electric freight could intensify that burden. As electric trucks replace diesel models, their heavier batteries could increase the city's yearly repair costs by up to nearly 12 percent by 2050.

Researchers at the Technion–Israel Institute of Technology have developed a pioneering approach that enables drugs to be produced directly inside the body using live, harmless bacteria. The technology, developed at the Faculty of Biotechnology and Food Engineering and published in Advanced Healthcare Materials, introduces a new paradigm for drug production and delivery.

Led by Prof. Boaz Mizrahi, Dr. Adi Gross, and Ph.D. student Caroline Hali Alperovitz, the study demonstrates how genetically modified bacteria can be introduced into target tissue, where they locally manufacture and secrete therapeutic substances. This method ensures fresh drug production, improves bioavailability, reduces side effects, and may allow long-lasting treatment from a single dose.

Using a dissolvable microneedle patch, the researchers safely delivered bacteria that produce γ-PGA, a protein important for wound healing and inflammation reduction. The technology showed effective and safe results in animal models and could transform future pharmaceutical treatments.

Humanitarian organisations must go beyond reactive compliance to data protection laws if they are to continue using technology in a principled, safe, and trusted way in the digital age, experts have said.

The Bezos Earth Fund has announced a $2 million grant to UC Davis, the American Heart Association and other partners to advance “Swap it Smart” as part of its AI for Climate & Nature Grand Challenge. The funding will support research that could help redesign foods, for example optimizing for flavor profile, nutritional properties and lower costs and environmental impact. Swap it Smart is an AI-powered recipe formulation tool in development by scientists at the UC Davis in collaboration with the Periodic Table of Food Initiative (PTFI), an entity of RF Catalytic Capital co-managed by the American Heart Association and Alliance of Bioversity CIAT and developed by The Rockefeller Foundation.